期刊文献+

miR-32-5p和FKBP14基因转染对SPC-A1细胞增殖、迁移、侵袭的影响及其靶向关系验证 被引量:2

Effects of miR-32-5p and FKBP14 gene transfection on proliferation,migration and invasion of SPC-A1 cells and verification of their targeting relationship
下载PDF
导出
摘要 目的观察miR-32-5p和FK506结合蛋白14(FKBP14)基因转染对人非小细胞肺癌(NSCLC)细胞系SPC-A1增殖、迁移、侵袭能力的影响,并验证两者之间靶向关系。方法选取SPC-A1细胞,将细胞为A、B、C、D、E、F组,分别转染miR-32-5p+pcDNA-FKBP14、miR-32-5p+pcDNA、miR-32-5p、miR-con、pcDNA-FKBP14、pcDNA-con,采用MTT法检测细胞吸光度值,并计算细胞存活率;Transwell实验检测细胞迁移数、侵袭数,Western blotting法检测细胞CyclinD1、MMP-2、MMP-9蛋白相对表达量。取SPC-A1细胞,将细胞分为G、H、I、J组,分别转染FKBP14-WT+miR-con、FKBP14-WT+miR-32-5p、FKBP14-MUT+miR-con、FKBP14-MUT+miR-32-5p,采用荧光素酶活性检测试剂盒检测细胞荧光素酶活性。取SPC-A1细胞,将细胞分为K、L、M、N组,分别转染miR-32-5p、miR-con、anti-miR-32-5p、anti-miR-con,Western blotting法检测细胞中KBP14蛋白相对表达量。结果与B组比较,A组细胞存活率、迁移细胞数、侵袭细胞数及CyclinD1、MMP-2、MMP-9蛋白相对表达量增加(P均<0.05);与D组比较,C组细胞存活率、迁移细胞数、侵袭细胞数及CyclinD1、MMP-2、MMP-9蛋白相对表达量减少(P均<0.05);与F组比较,E组SPC-A1细胞存活率、迁移细胞数、侵袭细胞数及CyclinD1、MMP-2、MMP-9蛋白相对表达量增加(P均<0.05)。与G组比较,H组细胞荧光素酶活性减弱(P<0.05);与I组比较,J组细胞荧光素酶活性无显著变化(P>0.05)。与L组比较,K组FKBP14蛋白相对表达量减少(P<0.05);与N组比较,M组FKBP14蛋白相对表达量增加(P<0.05)。结论过表达miR-32-5p或敲减FKBP14后SPC-A1细胞存活率降低,迁移细胞数、侵袭细胞数减少,miR-32-5p与FKBP14存在靶向调控关系。 Objective To observe the effects of miR-32-5 p and FK506 binding protein 14(FKBP14)gene transfection on the proliferation,migration and invasion of non-small-cell lung cancer(NSCLC)cell line SPC-A1,and to verify the targeting relationship between them.Methods SPC-A1 cells were were divided into the groups A,B,C,D,E,and F,and were transfected with miR-32-5 p+pcDNA-FKBP14,miR-32-5 p+pcDNA,miR-32-5 p,miR-con,pcDNA-FKBP14,and pcDNA-con;MTT method was used to detect cell absorbance value and we calculated the cell survival rate;Transwell test was used to detect the number of migrating cells and the number of invasive cells;Western blotting was used to detect the relative expression levels of CyclinD1,MMP-2,and MMP-9 proteins in cells.SPC-A1 cells were divided into the groups G,H,I,and J,and were transfected with FKBP14-WT+miR-con,FKBP14-WT+miR-32-5 p,FKBP14-MUT+miR-con,and FKBP14-MUT+miR-32-5 p;luciferase activity detection kit was used to detect the cellular luciferase activity.SPC-A1 cells were divided into the groups K,L,M,and N,and were transfected with miR-32-5 p,miR-con,anti-miR-32-5 p,and anti-miR-con;Western blotting was used to detect the relative expression of KBP14 protein.Results Compared with the group B,the cell survival rate,the number of migrating cells,the number of invasive cells,and relative expression of CyclinD1,MMP-2 and MMP-9 protein in the A group increased(P<0.05);compared with the D group,the cell survival rate,the number of migrating cells,the number of invasive cells,and relative expression of CyclinD1,MMP-2 and MMP-9 protein in the group C decreased(all P<0.05);compared with the group F,the cell survival rate,the number of migrating cells,the number of invasive cells,and relative expression of CyclinD1,MMP-2 and MMP-9 protein in the group E increased(all P<0.05).Compared with the group G,the luciferase activity of group H was weakened(P<0.05);compared with the group I,the luciferase activity of group J had no significant change(P>0.05).Compared with the group L,the relative expression of FKBP14 protein in the group K decreased(P<0.05);compared with the group N,the relative expression of FKBP14 protein in the group M decreased(P<0.05).Conclusion After over-expressing miR-32-5 p or knocking down FKBP14,the survival rate of SPC-A1 cells,the number of migrating cells,and the number of invasive cells decreased,and there was a targeted regulation relationship between miR-32-5 p and FKBP14.
作者 杨丹芬 谢圆媛 姜棚菲 白娟 林芳 YANG Danfen;XIE Yuanyuan;JIANG Pengfei;BAI Juan;LIN Fang(The Affiliated Hospital of Yan an University,Yan'an 716000,China)
出处 《山东医药》 CAS 2020年第24期17-21,共5页 Shandong Medical Journal
关键词 非小细胞肺癌 微小RNA-32-5p FK506结合蛋白14 细胞增殖能力 细胞迁移能力 细胞侵袭能力 non-small-cell lung cancer microRNA-32-5p FK506 binding protein 14 cell proliferation ability cell migration ability cell invasion ability
  • 相关文献

参考文献8

二级参考文献39

  • 1马卓娅,汤华,李欣,刘民,吴海东,王晶.MicroRNA在六种不同器官肿瘤细胞系中的差异表达[J].中国肿瘤,2007,16(9):714-717. 被引量:9
  • 2Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].Cancer J Clinicians,2015,65(2):87-108.
  • 3Masters GA,Temin S,Azzoli CG,et al.Systemic therapy for stage iv non-small-cell lung cancer:American society of clinical oncology clinical practice guideline update[J].J Clin Oncology,2015,33(30):3488-3515.
  • 4Fuller-Pace FV.The DEAD box proteins DDX5(p68) and DDX17(p72):Multi-tasking transcriptional regulators[J].Biochimica et Biophysica Acta,2013,1829(8):756-763.
  • 5Fuller-Pace FV,Ali S.The DEAD box RNA helicases p68(Ddx5) and p72(Ddx17):Novel transcriptional co-regulators[J].Biochem Society Transactions,2008,36(Pt 4):609-612.
  • 6Fuller-Pace FV.DEAD box RNA helicase functions in cancer[J].RNA Biol,2013,10(1):121-132.
  • 7Janknecht R.Multi-talented DEAD-box proteins and potential tumor promoters:p68 RNA helicase(DDX5) and its paralog,p72 RNA helicase(DDX17)[J].Am J Translational Res,2010,2(3):223-234.
  • 8Zhu YP,Shen T ,Wang S.Progress in features and functions of RNA helicases Ddx5(p68) and Ddx17(p72)[J].Sheng Li Ke Xue Jin Zhan,2012,43(4):294-297.
  • 9Alqahtani H,Gopal K,Gupta N,et al.DDX17(P72),a Sox2 binding partner,promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer[J].Cellular Signalling,2015,28(2):42-50.
  • 10Causevic M,Hislop RG,Kernohan NM,et al.Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours[J].Oncogene,2001,20(53):7734-7743.

共引文献29

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部